Development of Freeze-Dried Injectable Formulation for the Novel Lipid A Analog, E5531
スポンサーリンク
概要
- 論文の詳細を見る
A sonicated dispersion of the novel lipid A analog, E5531, was feeze-dried in the presence of various additives such as saccharides and polyalcohols, and their cryoprotective effects were investigated. Fusion of the vesicles was examined by measuring fluorescence energy transfer and size distribution. The ability as cryoprotectants differed among the addtive species. The addition of polyalcohols led to considerable fusion. Although monosaccharides, similar to disaccharides, completely prevented the fusion of the vesicles during lyophilization, they showed far less ability to retain the entrapped calcein in the vesicles compared to disaccharides. Differential scanning calorimetry heating profiles of vesicles that had been lyophilized with various additives were obtained. Disaccharides and monosaccharides again resulted in markedly different thermal properties of the vesicles. This variety in cryoprotective ability of saccharide species can be attributed to differences in their interaction with the E5531 head group.
- 日本油化学会の論文
著者
関連論文
- Formation of Spherical Micelles by the Novel Platelet Activating Factor Receptor Antagonist, E5880
- The Effect of the Lipid A Analog, E5531 on Fever Induced by Endotoxin from Escherichia coli
- Characterization of the Physicochemical Properties of the Micelle of the Novel Platelet Factor Receptor Antagonist, E5880
- Characterization of the Physicochemical Properties of Micelles of the Novel Platelet Activating Factor Receptor Antagonist, E5880
- Development of Freeze-Dried Injectable Formulation for the Novel Lipid A Analog, E5531
- Cryoprotective Effects of Saccharides on the Freeze-Drying of Sonicated Vesicles of the Lipid A Analog, E5531
- Effects of Calcium Ion on the Physicochemical Properties of Particles of A Lipid A Analog, E5531 and Its Pharmacokinetics in Rats
- Formation of the Dispersed Particles Composed of Soybean Oil and Phosphatidylcholine
- Development of an Injectable Formulation for the Novel Lipid A Analog E5531 Using a`pH-jump Method'
- Interaction of α-Tocopherol Acetate with Phosphatidylcholine and Their Formation of Small Dispersed Particles
- Development of an Injectable Formulation of the Novel Lipid A Analog E5531
- Characterization of the Physicochemical Properties of Micelles Composed of a Novel Platelet Factor Receptor Antagonist, E5880
- The Interaction of Menaquinone-4 with Phopholipid Membranes
- Effect of a Dynorphin A Analog, E2078,on Phospholipid Membrane Properties
- Investigation on the relationship between the physicochemical properties of particles composed of a novel lipid A analog, E5531, and its pharmacokinetics
- Characterization of the Physicochemical Properties of Micelles of the Novel Platelet Activating Factor Receptor Antagonist, E5880
- Cryoprotective Effects of Saccharides on the Freeze-Drying of Sonicated Vesicles of the Lipid A Analog, E5531
- Effects of Calcium Ion on the Physicochemical Properties of Particles of A Lipid A Analog, E5531 and Its Pharmacokinetics in Rats
- Phase Characteristics of Dispersed Particles Composed of Retinal and Dipalmitoylphosphatidylcholine